Non-analgesic effects of opioids: The cognitive effects of opioids in chronic pain of malignant and non-malignant origin. An update

Current Pharmaceutical Design

Volumn 18, Issue 37, 2012, Pages 6116-6122

  Højsted, Jette ^a   Kurita, Geana Paula ^a   Kendall, Sally ^b   Lundorff, Lena ^c   Pimenta, Cibele Andrucioli de Mattos ^d   Sjøgren, Per ^a  

^a Rigshospitalet   (Denmark)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c HERNING HOSPITAL   (Denmark)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cancer pain; Chronic pain; Cognition; Neuropsychological assessment; Opioid; Systematic review

Indexed keywords

BUPRENORPHINE; FENTANYL; MORPHINE; OXYCODONE;

ALERTNESS; ANALGESIA; ANXIETY DISORDER; ATTENTION; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PATIENT; CHRONIC PAIN; COGNITION; COGNITIVE DEFECT; DEPRESSION; DIABETIC NEUROPATHY; DRUG BLOOD LEVEL; DRUG EFFECT; EXECUTIVE FUNCTION; FIBROMYALGIA; HUMAN; INFORMATION PROCESSING; LONG TERM CARE; LOW BACK PAIN; MINI MENTAL STATE EXAMINATION; MOTOR COORDINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; REACTION TIME; REVIEW; TREATMENT OUTCOME; VERBAL MEMORY; WHIPLASH INJURY; WORKING MEMORY;

ANALGESICS, OPIOID; CHRONIC PAIN; COGNITION; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEOPLASMS;

EID: 84873974977     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212803582522     Document Type: Review

References (90)

1. Zacny J. A review of the effects of opioids in psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacol 1995; 3: 432-66.
2. Mao J. NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res Brain Res Rev 1999; 30: 289-304.
3. Kurita GP, Lundorff L, Pimenta CA, et al. The cognitive effects of opioids in cancer: a systematic review. Support Care Cancer 2009; 17: 11-21.
4. Kendall SE, Sjogren P, Pimenta CA, et al. The cognitive effects of opioids in chronic non-cancer pain. Pain 2010; 150: 225-30.
5. McCracken LM, Iverson GL. Predicting complaints of impaired cognitive functioning in patients with chronic pain. Jour Pain Symptom Manage 2001; 21: 392-6.
6. Barsevick AM, Whitmer K, Nail LM, et al. Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage 2006; 31: 85-95.
7. Hanks GW, Conno F, Cherny N, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 2001; 84: 587-93.
8. Eriksen J, Sjøgren P, Bruera E, et al. Critical issues on opioids in chronic non-cancer pain. An epidemiological study. Pain 2006; 125: 172-6.
9. Lawlor PG. The panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisal. Cancer 2002; 94: 1836-53.
10. Lezak M, Howieson D, Loring D. Neuropsychological Assessment. 4th ed. New York: Oxford University Press, 2004.
11. Hass B, Lungershausen J, Hertel N, et al. Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach. Eur J Health Econ 2009; 10: 309-21.
12. Majdzadeh R, Feiz-Zadeh A, Rajabpour Z, et al. Opium consumption and the risk of traffic injuries in regular users: a casecrossover study in an emergency department. Traffic Inj Prev 2009; 10: 325-9.
13. Dubois S, Bedard M, Weaver B. The association between opioid analgesics and unsafe driving actions preceding fatal crashes. Accid Anal Prev 2010; 42: 30-7.
14. Sjogren P, Gronbaek M, Peuckmann V, et al. A Population-based Cohort Study on Chronic Pain: The Role of Opioids. Clin J Pain 2010; 26: 763-9.
15. Ersek M, Cherrier MM, Overman SS, et al. The cognitive effect of opioids. Pain Management Nursing 2004; 5: 75-93.
16. Borsook D, Sava S, Becerra L. The pain imaging revolution: advancing pain into the 21st century. Neuroscientist 2010; 16: 171-85.
17. Seminowicz DA, Davis KD. Pain enhances functional connectivity of a brain network evoked by performance of a cognitive task. J Neurophysiol 2007; 97: 3651-9.
18. Moriarty O, McGuire BE, Finn DP. The effect of pain on cognitive function: A review of clinical and preclinical research. Prog Neurobiol 2011; 93: 385-404.
19. Eccleston C, Crombez G. Pain demands attention: a cognitiveaffective model of the interruptive function of pain. Psychol Bull 1999; 125: 356-66.
20. Legrain V, Damme SV, Eccleston C, et al. A neurocognitive model of attention to pain: behavioral and neuroimaging evidence. Pain 2009; 144: 230-2.
21. Airaksinen E, Larsson M, Forsell Y. Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction. J Psychiatr Res 2005; 39: 207-14.
22. Zakzanis KK, Leach L, Kaplan E. On the nature and pattern of neurocognitive function in major depressive disorder. Neuropsychiatry Neuropsychol Behav Neurol 1998; 11: 111-9.
23. Austin MP, Mitchell P, Goodwin GM. Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 2001; 178: 200-6.
24. Brown SC, Glass JM, Park DC. The relationship of pain and depression to cognitive function in rheumatoid arthritis patients. Pain 2002; 96: 279-84.
25. Porter RJ, Gallagher P, Thompson JM, et al. Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry 2003; 182: 214-20.
26. Airaksinen E, Wahlin A, Larsson M, et al. Cognitive and social functioning in recovery from depression: results from a populationbased three-year follow-up. J Affect Disord 2006; 96: 107-10.
27. Hasselbalch BJ, Knorr U, Kessing LV. Cognitive impairment in the remitted state of unipolar depressive disorder: A systematic review. J Affect Disord 2010.
28. Højsted J, Sjøgren P. An update on the role of opioids in the management of chronic pain of non-malignant origin. Curr Opin Anaesthesiol 2007; 20: 451-5.
29. Young-McCaughan S, Miaskowski C. Measurement of opioidinduced sedation. Pain Manag Nurs 2001; 2: 132-49.
30. Chapman SL, Byas-Smith MG, Reed B. Effects of intermediate and long-term use of opioids on cognition in patients with chronic pain. The Clinical Journal of Pain 2002; 18: S83-S90.
31. Kress HG, Kraft B. Opioid medication and driving ability. Eur Jour Pain 2005; 9: 141-4.
32. Kurita GP, Pimenta CA, Nobre MR. [Opioids and cognition in patients with chronic pain: a systematic review]. Rev Assoc Med Bras 2008; 54: 529-36.
33. Christo PJ. Opioid effectiveness and side effects in chronic pain. Anesthesiol Clin North America 2003; 21: 699-713.
34. Strassels SA. Cognitive effects of opioids. Curr Pain Headache Rep 2008; 12: 32-6.
35. Nilsen HK, Landro NI, Kaasa S, et al. Driving functions in a video simulator in chronic non-malignant pain patients using and not using codeine. Eur J Pain 2011; 15: 409-15.
36. Fletcher R, Fletcher S, Wagner E. Clinical Epidemiology. 4th ed. Baltimore: Lippincott Williams & Wilkins, 2005.
37. Phillips B, Sackett D, Badenoch D, et al. Oxford Centre for Evidence-based Medicine-levels of evidence. 2009.
38. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
39. Raja SN, Haythornthwaie JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia. Neurology 2002; 59: 1015-21.
40. Jamison RN, Schein JR, Vallow S, et al. Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage 2003; 26: 913-21.
41. Rowbotham MC, Twilling L, Davis PS, et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Eng J Med 2003; 348: 1223-32.
42. Haythornthwaite JA, Menefee LA, Quatrano-Piacentini AL, et al. Outcome of chronic opioid therapy for non-cancer pain. J Pain Symptom Manage 1998; 15: 185-94.
43. Tassain V, Attal N, Fletcher D, et al. Long term effects of oral sustanied release morphine on neuropsychological performance in patients with chronic non-cancer pain. Pain 2003; 104: 389-400.
44. Sjøgren P, Thomsen AB, Olsen AK. Impaired neuropsychological performance in chronic nonmalignant pain patients receiving longterm oral opioid therapy. J Pain Symptom Manage 2000; 19: 100-8.
45. Galski T, Williams J, Ehle H. Effects of opioids on driving ability. Jour Pain Symptom Manage 2000; 19: 200-8.
46. Sabatowski R, Schwalen S, Rettig K, et al. Driving ability under long-term treatment with transdermal fentanyl. J Pain Symptom Manage 2003; 25: 38-47.
47. Byas-Smith M, Chapman S, Reed B, et al. The effects of opioids on driving and psychomotor performance in patients with chronic pain. Clin J Pain 2005; 21: 345-52.
48. Sjøgren P, Christrup L, Petersen MA, et al. Neuropsychological assessment of chronic non-malignant pain patients treated in a multidisciplinary pain centre. Eur J Pain 2005; 9: 453-62.
49. Gaertner J, Radbruch L, Giesecke T, et al. Assessing cognition and psychomotor function under long-term treatment with controlled release oxycodone in non-cancer pain patients. Acta Anaesthesiol Scand 2006; 50: 664-72.
50. Won A, Lapane KL, Vallow S, et al. Long-term effects of analgesics in a population of elderly nursing home residents with persistent nonmalignant pain. J Gerontol 2006; 61A: 165-9.
51. Dagtekin O, Gerbershagen HJ, Wagner W, et al. Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients. Anesth Analg 2007; 105: 1442-8, table.
52. Rowbotham MC, Twilling L, Davies PS, et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003; 348: 1223-32.
53. Wefel JS, Lenzi R, Theriault RL, et al. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 2004; 100: 2292-9.
54. Bender CM, Sereika SM, Berga SL, et al. Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 2006; 15: 422-30.
55. Strömgren AS. Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology. Cancer 2002; 94: 512-20.
56. Ventafridda V, Ripamonti C, De CF, et al. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 1990; 6: 7-11.
57. Stiefel F, Holland J. Delirium in cancer patients. Int Psychogeriatr 1991; 3: 333-6.
58. Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 1997; 79: 835-42.
59. Folstein MF, Fetting JH, Lobo A, et al. Cognitive assessment of cancer patients. Cancer 1984; 53: 2250-7.
60. Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 2000; 160: 786-94.
61. Levine PM, Silberfarb PM, Lipowski ZJ. Mental disorders in cancer patients: a study of 100 psychiatric referrals. Cancer 1978; 42: 1385-91.
62. Massie MJ, Holland J, Glass E. Delirium in terminally ill cancer patients. Am J Psychiatry 1983; 140: 1048-50.
63. Sjogren P. Psychomotor and cognitive functioning in cancer patients. Acta Anaesthesiol Scand 1997; 41: 159-61.
64. Joly F, Rigal O, Noal S, et al. Cognitive dysfunction and cancer: which consequences in terms of disease management? Psychooncology 2011.
65. Pullens MJ, De VJ, Roukema JA. Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psychooncology 2010; 19: 1127-38.
66. Kurita GP, Pimenta CA. Cognitive impairment in cancer pain patients receiving opioids. Cancer Nurs 2008; 31: 57.
67. Christrup LL, Sjogren P, Jensen NH, et al. Steady-state kinetics and dynamics of morphine in cancer patients: is sedation related to the absorption rate of morphine? J Pain Symptom Manage 1999; 18: 164-73.
68. Kamboj SK, Tookman A, Jones L, et al. The effects of immediaterelease morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain 2005; 117: 388-95.
69. Bruera E, Macmillan K, Hanson J, et al. The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain 1989; 39: 13-6.
70. Sjøgren P, Banning A. Pain, sedation and reaction time during long-term treatment of cancer patients with oral and epidural opioids. Pain 1989; 39: 5-11.
71. Banning A, Sjogren P. Cerebral effects of long-term oral opioids in cancer patients measured by continuous reaction time. Clin J Pain 1990; 6: 91-5.
72. Banning A, Sjogren P, Kaiser F. Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids. Acta Anaesthesiol Scand 1992; 36: 480-2.
73. Sjogren P, Banning AM, Christensen CB, et al. Continuous reaction time after single dose, long-term oral and epidural opioid administration. Eur J Anaesthesiol 1994; 11: 95-100.
74. Vainio A, Ollila J, Matikainen E, et al. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 1995; 346: 667-70.
75. Sjøgren P, Olsen AK, Thomsen AB, et al. Neuropsychological performance in cancer patients: the role of oral opioids, pain and performance status. Pain 2000; 86: 237-45.
76. Clemons M, Regnard C, Appleton T. Alertness, cognition and morphine in patients with advanced cancer. Cancer Treat Rev 1996; 22: 451-68.
77. Moulin DE, Lezzi A, Amireh R, et al. Randomized trial of oral morphine for chronic non-cancer pain. Lancet 1996; 347: 143-7.
78. Lorenz J, Beck H, Bromm B. Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain. Pain 1997; 73: 375.
79. Eriksen J, Jensen MK, Sjøgren P, et al. Epidemiology of chronic non-malignant pain in Denmark. Pain 2003; 106: 221-8.
80. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009; 10: 113-30.
81. Meyers CA, Wefel JS. The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol 2003; 21: 3557-8.
82. Smith A. Symbol-digit modalities test. Western Psychological Services Los Angeles 1991.
83. Reitan R. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271-6.
84. Jensen AR, Rohwer WD, Jr. The Stroop color-word test: a review. Acta Psychol (Amst) 1966; 25: 36-93.
85. Peters M. Prolonged practice of a simple motor task by preferred and non-preferred hands. Percept Mot Skills 1976; 42: 447-50.
86. Elsass P. Continuous reaction times in cerebral dysfunction. Acta Neurol Scand 1986; 73: 1-22.
87. Lezak M. Neurobehavioral variables and diagnostic issues. Neuropsychological assessment New York: Oxford University Press, 1995: 277-331.
88. WHO. WHO's Pain Relieving Ladder. 2007.
89. Wood MM, Ashby MA, Somogyi AA, et al. Neuropsychological and pharmacokinetic assessment of hospice inpatients receiving morphine. J Pain Symptom Manage 1998; 16: 112-20.
90. Klepstad P, Borchgrevink PC, Dale O, et al. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients. Palliat Med 2003; 17: 679-87.